CSIMarket
 
Axcelis Technologies Inc  (NASDAQ: ACLS)
 
Price: $110.3700 $-0.40 -0.361%
Day's High: $111.93990325927734 Week Perf: -4.5 %
Day's Low: $ 107.87 30 Day Perf: -19.24 %
Volume (M): 248,529 52 Wk High: $ 193.78
Volume (M$): $ 0 52 Wk Avg: $110.31
Open: $110.24 52 Wk Low: $73.60



 Market Capitalization (Millions $) 3,419
 Shares Outstanding (Millions) 31
 Employees 1,465
 Revenues (TTM) (Millions $) 845
 Net Income (TTM) (Millions $) 101
 Cash Flow (TTM) (Millions $) -30
 Capital Exp. (TTM) (Millions $) 8

Business Description


Axcelis Technologies, Inc. (designs, manufactures and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. We believe that our Purion family of products are the most innovative implanters available on the market today. We sell to leading semiconductor chip manufacturers worldwide. In addition to equipment, we provide extensive aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services and customer training.

Ion Implantation Systems

Ion implantation is a principal step in the transistor formation cycle of the semiconductor manufacturing process. An ion implanter is a large, technically advanced system that injects dopants such as arsenic, boron or phosphorus into a wafer. These dopants are ionized and therefore have electric charges. With an electric charge they can be manipulated, moved and accelerated with electric and magnetic fields. Ion implanters use these fields to create a beam of ions with a precisely defined amount of energy (ranging between several hundred and three million electron-volts) and with a precisely defined amount of beam current (ranging from microamps to milliamps). Certain areas of the silicon wafer are blocked off by a polymer material known as photoresist, which acts as a "stencil" to pattern devices so that the dopants will only enter the wafer where needed. The dopants change the electrical properties of the silicon wafer to create the active components of a chip, called the transistors. Typical process flows require twenty implant steps, with the most advanced processes requiring thirty or more. Each implant step is characterized by four key parameters: dopant type, dose (amount of dopant), energy (depth into the silicon) and tilt (angle of wafer relative to the ion beam).

In order to cover the wide range of implant steps, three different types of implanters have been developed, each designed to cover a specific range of applications, primarily defined by dose and energy. The three traditional implanter types are referred to as medium current, high current and high energy:

• Medium current implanters are the original model of ion implanter, with mid to low-range energy and dose capability.

• High current implanters were the second type of implanter to emerge, having low energy capability and high dose range.

• High energy implanters emerged to address the need for deeper implants with a high energy range and low dose.

The Purion Platform and Family of Ion Implanters

Axcelis offers a complete line of high energy, high current and medium current implanters for all application requirements. Our flagship systems are all based on a common Purion platform which offers purity, precision and productivity by combining a high-speed, state-of-the-art single wafer end station, enabling unmatched throughput (500 wafers per hour), and an advanced spot beam that ensures that all points across the wafer see the same beam at the same beam angle, resulting in exceptional process control and maximum yield.

• High Energy Implant. Our Purion XE high energy system, combines Axcelis production-proven RF Linac high energy, spot beam technology with the Purion platform. Axcelis is a market leader in high energy ion implanters, and we expect to maintain our leadership in the high energy segment through sales of both our multi-wafer legacy high energy systems and the Purion XE. In 2015, we secured three new customers for the Purion XE in six different fabrication facilities. We also introduced the Purion VXE, which offers a higher energy range.

• Medium Current Implant. Our Purion M medium current system offers higher productivity and lower cost of ownership than competitive offerings, in addition to other advantages. Four customers, in both the memory and leading edge foundry segments, have the Purion M in production in 2015. We received follow-on orders from existing customers and obtained a new customer Purion M design-win. We also invested in technology that facilitates the manufacture of specialty devices on the Purion M, such as silicon carbide.

• High Current Implant. Our Purion H high current system fulfills all traditional high current requirements while extending beyond traditional high current energy and dose ranges. In order to maximize utilization and flexibility, the Purion H can process some traditional mid-current

implants. In addition, the Purion H is extendable into ultra-low energy applications to satisfy future process requirements, including leakage current performance. We currently have four customers using the Purion H in production, and in 2015 we received multiple orders from one leading edge memory customer.



   Company Address: 108 Cherry Hill Drive Beverly 1915 MA
   Company Phone Number: 787-4000   Stock Exchange / Ticker: NASDAQ ACLS


Customers Net Income grew by ACLS's Customers Net Profit Margin grew to

29.99 %

14.79 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ASYS   -9.22%    
AMAT   -9.63%    
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 34.60
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 4.04
Price to Sales (Expected) -
Price to Book 3.27
PEG (TTM) -

Financial Strength Current
Quick Ratio 1.8
Working Capital Ratio 4.59
Leverage Ratio (MRQ) 0.32
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) 3.19 $
Revenues (TTM) 27.29 $
Cash Flow (TTM) -
Cash 11.83 $
Book Value 33.72 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 577,093
Net Income per Employee (TTM) 68,855
Receivable Turnover Ratio (TTM) 5.48
Inventory Turnover Ratio (TTM) 1.48
Asset Turnover Ratio (TTM) 0.62

Profitability Ratios Current
Gross Margin (MRQ) 40.5 %
Operating Margin (MRQ) 4 %
Net Margin (MRQ) 4.63 %
Net Cash Flow Margin (MRQ) 2.7 %
Effective Tax Rate (TTM) 12.88 %

Management Effectiveness Current
Return On Assets (TTM) 7.46 %
Return On Investment (TTM) 8.71 %
Return On Equity (TTM) 9.79 %
Dividend Yield -
Pay out Ratio (TTM) -



Axcelis Technologies Inc's Segments
North America    11.44 % of total Revenue
Asia Pacific    72.59 % of total Revenue
Europe    15.97 % of total Revenue
Systems    63.49 % of total Revenue
Aftermarket    36.51 % of total Revenue
Single segments    100 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.